World News | Jason Gale and Naomi Kresge, Bloomberg | Thursday December 9, 2021
The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters
www.ndtv.com